Skip to Main Content

Apotex to Pay $24.1 Million to Resolve Price-Fixing Allegations

  • May 08, 2020

Generic drug company Apotex Corp. agreed to pay $24.1 million to settle criminal allegations that it conspired with other sellers to fix prices of the widely used cholesterol medication pravastatin, the Department of Justice (DOJ) announced May 7.

Keep reading this article by creating an account or logging in.